Direct-Acting Oral Anticoagulant Therapy in Cancer Patients—A Review

T Górnicki, K Bułdyś, D Zielińska, M Chabowski - Cancers, 2023 - mdpi.com
Simple Summary Direct-acting oral anticoagulants are becoming popular therapeutic option
in patients with cancer. We investigated the available literature in order to try to sum up the …

Diagnosis and management of acute lower gastrointestinal bleeding

Y Elimeleh, IM Gralnek - Current Opinion in Gastroenterology, 2024 - journals.lww.com
Diagnosis and management of acute lower gastrointestinal ble... : Current Opinion in
Gastroenterology Diagnosis and management of acute lower gastrointestinal bleeding …

Construction and validation of a nomogram of risk factors for new-onset atrial fibrillation in advanced lung cancer patients after non-surgical therapy

J Chen, S Cao, Y Jin, W Rong, H Wang, S Xi… - Frontiers in …, 2023 - frontiersin.org
Objective Risk factors of new-onset atrial fibrillation (NOAF) in advanced lung cancer
patients are not well defined. We aim to construct and validate a nomogram model between …

[HTML][HTML] Real-world evidence of direct oral anticoagulants in patients with atrial fibrillation and cancer: A meta-analysis

X Li, R Li, W Zhu, D Wu - IJC Heart & Vasculature, 2024 - Elsevier
Background Several observational cohort studies have been conducted to investigate the
effectiveness and safety of direct oral anticoagulants (DOACs) compared with vitamin K …

[HTML][HTML] Development and validation of a clinical decision support system to prevent anticoagulant duplications

H Dahmke, F Cabrera-Diaz, M Heizmann… - International Journal of …, 2024 - Elsevier
Abstract Background and Objective Unintended duplicate prescriptions of anticoagulants
increase the risk of serious adverse events. Clinical Decision Support Systems (CDSSs) can …

Nonvitamin K oral anticoagulants with proton pump inhibitor cotherapy ameliorated the risk of upper gastrointestinal bleeding

P Chaiyana, K Techathuvanan, S Sethasine - Scientific Reports, 2023 - nature.com
Proton pump inhibitors (PPIs) can reduce the risk of upper gastrointestinal bleeding (UGIB)
in patients who are taking oral anticoagulants. This study aimed to identify the association …

Bleeding Risk in Patients with Cancer

C Englisch, N Vladic, C Ay - Hämostaseologie, 2024 - thieme-connect.com
The hemostatic system and cancer display a tight interconnection, and hemostatic
imbalance frequently occurs in patients with cancer. While extensive knowledge about …

Causal relationship between atrial fibrillation/warfarin and cutaneous melanoma: a two-sample Mendelian randomization study

W Xiaowu, Z Qiang, H Yike, Z Wu, J Yiheng… - Frontiers in …, 2024 - frontiersin.org
Purpose In recent years, the relationship between malignant tumors and atrial fibrillation has
attracted more and more attention. Atrial fibrillation can also cause a series of adverse …

Clinical outcomes and mortality in patients with atrial fibrillation and recently diagnosed lung cancer in oncology outpatient settings.

APLF De Heredia, MR Ortiz, AIP Cabeza… - Current Problems in …, 2023 - Elsevier
Introduction Our aim was to investigate the prevalence of atrial fibrillation (AF) and recently
diagnosed lung cancer in the outpatient oncology clinic and to describe the clinical profile …

Another meta-analysis on novel oral anticoagulants for left ventricular thrombus: when enough is enough?

FM Martino, M Bernardi, A Pingitore… - Journal of …, 2023 - journals.lww.com
Nonvitamin K oral anticoagulants (NOAC) were firstly introduced in 2008, and interest in
their possible role in treating multiple thrombotic illnesses has been growing ever since. 1 …